Sangamo Therapeutics (SGMOQ) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | 2.25% |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 7.34% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 18.35% |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | -12.33% |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | -3.86% |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -38.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -38.27% |
| Sep 30, 2025 | -22.73% |
| Jun 30, 2025 | -23.70% |
| Mar 31, 2025 | -23.35% |
| Dec 31, 2024 | -33.44% |
| Sep 30, 2024 | -32.67% |
| Jun 30, 2024 | -66.04% |
| Mar 31, 2024 | -63.23% |
| Dec 31, 2023 | -57.70% |
| Sep 30, 2023 | -49.21% |
| Jun 30, 2023 | 13.49% |
| Mar 31, 2023 | 16.04% |
| Dec 31, 2022 | 23.31% |
| Sep 30, 2022 | 10.17% |
| Jun 30, 2022 | 7.89% |
| Mar 31, 2022 | 14.10% |
| Dec 31, 2021 | 24.68% |
| Sep 30, 2021 | 44.03% |
| Jun 30, 2021 | 46.25% |
| Mar 31, 2021 | 44.51% |